<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>1220</number>
    <updateDate>2022-11-15T16:34:45Z</updateDate>
    <updateDateIncludingText>2022-11-15T16:34:45Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2013-03-15</introducedDate>
    <congress>113</congress>
    <constitutionalAuthorityStatementText><![CDATA[<pre>From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. BURGESS:H.R. 1220.Congress has the power to enact this legislation pursuantto the following:The attached legislation falls within Congress' authorityto regulate interstate commerce as found in Article I,Section 8, clause 3 of the U.S. Constitution, which providesthe authority for the congress ``To regulate Commerce withforeign Nations, and among the several States, and with theIndian Tribes.'' The epinephrine inhalers at issue in theattached legislation are regulated by the federal Food andDrug Administration (FDA), and the propellant at issue isregulated by the Environmental Protection Agency. The productfurther falls within the subject matter of an internationaltreaty known as the Montreal Protocol on Substances thatDeplete the Ozone Layer, of which the U.S. is a signatory.[Page H1549]</pre>]]></constitutionalAuthorityStatementText>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif03</systemCode>
            <name>Energy, Climate and Grid Security Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2013-03-15T18:58:03Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2013-03-15T13:01:15Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2013-03-15</actionDate>
        <committees>
          <item>
            <systemCode>hsif03</systemCode>
            <name>Energy, Climate and Grid Security Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Energy and Power.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2013-03-15</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2013-03-15</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2013-03-15</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>B001248</bioguideId>
        <fullName>Rep. Burgess, Michael C. [R-TX-26]</fullName>
        <firstName>Michael</firstName>
        <lastName>Burgess</lastName>
        <party>R</party>
        <state>TX</state>
        <middleName>C.</middleName>
        <district>26</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>D000355</bioguideId>
        <fullName>Rep. Dingell, John D. [D-MI-12]</fullName>
        <firstName>JOHN</firstName>
        <lastName>DINGELL</lastName>
        <party>D</party>
        <state>MI</state>
        <middleName>D.</middleName>
        <district>12</district>
        <sponsorshipDate>2013-03-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M001142</bioguideId>
        <fullName>Rep. Matheson, Jim [D-UT-4]</fullName>
        <firstName>JIM</firstName>
        <lastName>MATHESON</lastName>
        <party>D</party>
        <state>UT</state>
        <district>4</district>
        <sponsorshipDate>2013-03-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001051</bioguideId>
        <fullName>Rep. Carter, John R. [R-TX-31]</fullName>
        <firstName>John</firstName>
        <lastName>Carter</lastName>
        <party>R</party>
        <state>TX</state>
        <middleName>R.</middleName>
        <district>31</district>
        <sponsorshipDate>2013-03-19</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Environmental Protection</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative law and regulatory procedures</name>
        </item>
        <item>
          <name>Air quality</name>
        </item>
        <item>
          <name>Cardiovascular and respiratory health</name>
        </item>
        <item>
          <name>Climate change and greenhouse gases</name>
        </item>
        <item>
          <name>Environmental Protection Agency (EPA)</name>
        </item>
        <item>
          <name>Environmental regulatory procedures</name>
        </item>
        <item>
          <name>Health technology, devices, supplies</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Environmental Protection</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2013-03-15</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2013-03-25T19:45:22Z</updateDate>
        <text><![CDATA[ <p>Asthma Inhalers Relief Act of 2013 - Directs the Administrator of the Environmental Protection Agency (EPA) to: (1) permit the distribution, sale, and consumption in the United States of remaining inventories of CFC epinephrine inhalers manufactured pursuant to the exception for medical devices under the Clean Air Act; (2) not take any enforcement action or otherwise seek to restrict the distribution, sale, or consumption of such inhalers on the basis of any federal law implementing the Montreal Protocol on Substances that Deplete the Ozone Layer; and (3) issue, in response to a request of any distributor or seller of such inhalers, a No Action Assurance Letter stating that the EPA will not initiate an enforcement action relating to the distribution or sale of any such inhaler occurring prior to August 1, 2013.</p> <p>Defines "CFC epinephrine inhaler" to mean any epinephrine inhaler containing chlorofluorocarbons that was manufactured and classified as over-the-counter before January 1, 2012.</p> <p>Terminates this Act on August 1, 2013.</p>]]></text>
      </summary>
    </summaries>
    <title>Asthma Inhalers Relief Act of 2013</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Asthma Inhalers Relief Act of 2013</title>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Asthma Inhalers Relief Act of 2013</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To direct the Administrator of the Environmental Protection Agency to allow for the distribution, sale, and consumption in the United States of remaining inventories of over-the-counter CFC epinephrine inhalers.</title>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2013-03-15T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-113hr1220ih/xml/BILLS-113hr1220ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2013-03-15</actionDate>
      <text>Referred to the Subcommittee on Energy and Power.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
